Neurology ReviewsFDA expands atogepant approval to include chronic migraineMay 2, 2023Headache & MigrainePain
Neurology ReviewsResearchers seek to understand post-COVID autoimmune disease riskMay 1, 2023COVID-19 UpdatesLong COVID
Neurology ReviewsDonanemab bests aducanumab in head-to-head Alzheimer’s trialMay 1, 2023Alzheimer's & Cognition
Neurology ReviewsNew hope for adult children with ‘failure to launch’ syndromeMay 1, 2023PediatricsNeurodevelopmental Disorders
Neurology ReviewsCautious optimism for new Alzheimer’s disease biomarkers and treatments, expert saysMay 1, 2023Alzheimer's & Cognition
Neurology ReviewsMachine learning can predict primary progressive MS progressionApril 27, 2023Multiple Sclerosis
Neurology ReviewsUnawareness of memory slips could indicate risk for Alzheimer’sApril 27, 2023Alzheimer's & Cognition
Neurology ReviewsNoninvasive testing in midlife flags late-onset epilepsy riskApril 27, 2023Epilepsy & Seizures
Neurology ReviewsTherapy to reverse muscle dystrophies shows promiseApril 27, 2023Neuromuscular DisordersMovement Disorders
Neurology ReviewsAtogepant prevents episodic migraine in some difficult-to-treat casesApril 26, 2023Headache & Migraine
